A calpain unique alveolates essential Plasmodium falciparum knockdown reveals involvement pre-S-phase development
Ilaria Russo, Anna Oksman, Barbara Vaupel, Daniel E. Goldberg1
Departments Medicine Molecular Microbiology, Howard Hughes Medical Institute, Washington University School Medicine,
660 South Euclid Avenue, St. Louis, MO 63110

Edited Anthony Cerami, Warren Pharmaceuticals, Ossining, NY, approved November 21, 2008 (received review July 18, 2008)

Plasmodium falciparum encodes single calpain distinct           undertook genetic characterization assess essentiality domain composition restricted alveolates. evaluate                 gain insight function cell.
potential protein drug target, assessed essen-              report Pcalp distinct type calpain restricted tiality. gene disruption double cross gene trun-            alveolates. Using multiple approaches, gene cation single cross recombination failed.               essential intraerythrocytic parasites. developing conditional
unable achieve allelic replacement using missense mutation           knockdown  able examine gene function. catalytic cysteine codon, obtain synon-             Pcalp plays critical role cell cycle progression tropho-
ymous allelic replacement parasites. results suggested            zoite development. calpain gene proteolytic activity important optimal parasite growth. gain insight biological         Results
role, used FKBP degradation domain generate               Pcalp Distinct Type Calpain Restricted Alveolates. fusion protein stability transfected parasites             identified single calpain gene (Pcalp) P. falciparum,
modulated small FKBP ligand, Shield1 (Shld1).                 MAL13P1.310 locus. predicted coding region 6,147 bp,
calpain-GFP-FKBP fusion single cross integration             encodes 242-kDa protein, confirmed extensive se- endogenous calpain locus. Calpain levels knocked               quence analysis genomic DNA cDNA amplified parasite growth greatly impaired absence Shld1.            mature mRNA (SI Materials Methods). Orthologs Pcalp Parasites delayed ability transition ring        Plasmodium species sequence data stage ability progress S phase. Calpain            available (Table S1). phylogenetic analysis confirmed required cell cycle progression Plasmodium parasites              Pcalp greatest homology Aspergillus PalB (2), limited appears attractive drug target. shown                  catalytic domain.  low reliability node derivation
regulated knockdowns possible P. falciparum                indicates substantial divergence (Fig. 1). fact, aside central
useful evaluating essentiality function.                             calpain catalytic domain (IIa-b) C-terminal domain homol-
                                                                             ogous calpain domain III, Pcalp possesses long N terminus cell cycle å…© cysteine protease å…© essentiality å…© inducible å…© malaria          significant homology known protein. Pcalp distinct
                                                                             type calpain domain composition, common 
P    lasmodium falciparum, causative agent severe malaria,
     complex life cycle involving numerous biological events, migration, host cell invasion, metabolism, cell cycle
                                                                             identified calpain class (Fig. 1).
                                                                               sequenced apicomplexan parasite genomes encode single
                                                                             calpain N-terminal homology, progression egress. Cysteine proteases implicated           gene predictions result shorter encoded N terminus (Fig. 1). processes (1), function                 ciliate calpains, Tetrahymena Paramecium, estimated 35 members protease class encoded genome            N termini homology Pcalp. Bootstrap analysis defined. single calpain-like protease           domain composition indicate Pcalp belongs distinct clade
recognized (2).                                                              calpains restricted Apicomplexa alveolates
   Calpains belong C2 family cysteine proteases. Calpains          (Fig. 1). diatom Thalassiosira pseudonana, belongs organisms bacteria mammals exhibit great            chromalveolate kingdom, encoded calpain distant
divergence sequence domain structure homologous              N-terminal homology alveolate sequences  shown).
catalytic domains. Calpains implicated diverse pro-
cesses (3â€“6), muscle function, cell signaling, migration         Pcalp Expressed Early Intraerythrocytic Stages. pub-
attachment, death, transformation, cell-cycle regulation, differen-          lished Pcalp mRNA assessments differ (9, 10), tiation development, fungal alkali tolerance,           analyzed cDNA semiquantitative RT-PCR asexual
precise physiological role calpains poorly         development. Amplifying N-terminal C-terminal
understood (3, 7).
   Calpains divided typical (resembling calpain 1) atypical (lacking domain IV) (4, 5). typical calpains, domain IV          Author contributions: R. D.E.G. designed research; R., O., B.V. performed
mediates Ca2â«¹ binding consequently activity regulation               research; R. D.E.G. analyzed data; R. D.E.G. wrote paper.

dimerization (8). P. falciparum, 1 calpain gene (Pcalp)           authors declare conflict 
apparent genome (2), atypical. unusually          article PNAS Direct Submission.
long coding sequence, outside catalytic domain,          Freely available online PNAS open access option.
distant homology characterized calpains. Pcalp            Data deposition: sequences reported paper deposited GenBank
contains subdomains highly conserved related             database (accession nos. EF432831, EF432832, EF432833).
species confer uniqueness protein. deter-             1To   correspondence addressed. E-mail: goldberg@borcim.wustl.edu.
mines nucleolar localization, regulates calpain             article contains supporting information online www.pnas.org/cgi/content 
ment nucleus reversible palmitoylation             0806926106/DCSupplemental.
 R., unpublished data). Surprised location Pcalp,             Â© 2009 National Academy Sciences USA



1554 â€“1559 å…© PNAS å…© February 3, 2009 å…© vol. 106 å…©  5                                                         www.pnas.orgå…¾cgiå…¾doiå…¾10.1073å…¾pnas.0806926106
                                                                                                          B
                   0.05                                    Domains-> N-terminal Catalytic
                                                                                IIa IIb     III   IV
                                              Drosoph_CalpC
                                       Schisto_Calp                                                                                                                    Domains-> N-terminal Catalytic
                                                                                                                                                                                             IIa IIb III
                         68            Human_Calp9                                                             0.05
                                                                                                                                    100                      P. falciparum
                   77                 Human_Calp3                                                                            100
                        62     58      Murine_Calp8                                                                                                         P. reichenowi
                             95        Human_Calp2                                                                                                          P. gallinaceum
         63
                                      Human_Calp1                                                                            99
              63         72                                                                                                                                 P. chabaudii
                    50                 Human_Calp11                                                                                 100
                                100    Drosoph_CalpA                                                                         55                              P. yoelii
              40                       Drosoph_CalpB                                                                                100                      P. berghei
                    37                 C.elegans_clp-7
        80
                                       Human_Calp12                                                                                100                         P. vivax
             52                          Human_Calp13                                                                  100                                   P. knowlesi
                                        C.elegans_Tra3                                            C2
               98
                                        Human_Calp5                                                                                 100                              N. caninum
    48                                                                                                                       100
                   66                      Human_Calp6                                                                                                            T. gondii
                                           Human_Calp10
                                                                    ZnF_RBZ               SOLH                    98                                              E. tenella
                         100             Drosoph_CalpD
         62                              Human_SOLH TMs                                                                 70                                        B.bigemina
                                                                                                                             97
                                       Arabid._Dek1                                                                                                                  T. annulata
                                                                                          LyM                                                               100
        26                               Entamoeba_Calp
         64                                Trypanosome_Calp                                                                                                           T. parva
                                           Human_Calp7                   MIT               PBH
                    99                                                                                                                                       C.parvum
           58
                                            C.elegans_clp-2
         56                                                                                                     100                      P. tetraurelia
                                            PCalp
        91                                  Asperg_PalB                                                                                                                  T. therm.                  ?
                                                  C.neo_PalB
   18                                               Candidal_PalB
              80                                     S.cerevisiae_Rim13
                                              Gloeob._Glr4140          HemolysinCabind

         62                                      P.ging_Tpr
                                            C.elegans_F44F1.3

Fig. 1. Phylogenetic analysis reveals Pcalp distinct type clade calpains.   Phylogenetic analysis Pcalp (catalytic domain) aligned representatives documented type calpain shown (left  domain composition protein (right . Bootstrap values shown tree joints.
Domains color coded named appearance (SMART code). Pcalp N terminus subdomains conserved Plasmodium
species (green)  R., O., D.E.G., unpublished data). Scale fractional change unit distance. (B) Phylogenetic analysis domain composition alveolate
calpains. Crossed boxes denote incomplete sequence information. Sequence data listed Tables S1 S2 alignments Figs. S1 S2.



coding regions normalizing actin, peak                                       S phase 30 hpi (Fig. 2B), corresponding peak induction (2â«») late ring/early trophozoite stages [18â€“24                                        Pcalp.
hours postinvasion (hpi), Fig. 2A], consistent data Bozdech et al. (9).                                                                                    Pcalp Gene Activity Essential Optimal Growth.    Despite low expression levels, able detect Pcalp                                    assessed essentiality Pcalp optimal P. falciparum asexual Western blotting immunoprecipitation large num-                                        growth using multiple approaches (Fig. 3A). ber parasites (5 â«» 108). used parasite line (C3)                                  classical gene knockout approach using double cross                                                                                                        positive/negative selection (11). used double positive selection
endogenous calpain ORF tagged GFP  Materials                                                                                                        fusing HcRed hDHFR obtained red fluorescent parasites
Methods), anti-GFP antibody used visual-                                      stably maintained plasmid drug pressure (Fig. S4).
ization. asexual cycle monitored morphology DNA                                         unable recover integrants negative
content (Fig. 2B). Pcalp detected rings late                                          selection despite multiple attempts, assayed Southern blotting
trophozoites, showing peak cell midtropho-                                      (Fig. 3B) nested PCR (data shown).
zoites concentration (normalized BiP) rings (Fig. 2 C                                        gene disruption 5â¬˜ single cross  transfected 3D7 D). experiments, majority cells entered                                    parasites constructs containing 1.3 1.6 kb 5â¬˜ end 

Fig. 2. Expression profiles Pcalp asexual
cycle.   Semiquantitative RT-PCR analysis. Expression
                                                                12
                                                                                                                        ER   LR
                                                                                                                                            C
                                                                                                                                     ET MT MT/LT Sc
                                                                                                                                                      IP: R- -PCalp
                                                                10
                                                                                                                                                      WB: M- -GFP
                                                                          calpain/actin



 Pcalp mRNA asexual stages measured                                                                            rel intensity




                                                                  8
quantifying amplified regions encoding N (light                                                                                                      kDa
                                                                  6                                                                                      250
gray) C (dark gray) termini (map region Fig.
                                                                  4
S3). signals normalized actin. ER LR,                                                                                                    75
                                                                  2                                                                                   IP inputs
early late rings; ET LT, early late tropho-                                                                                               WB:   R - -BiP
                                                                  0                                                 hpi    9 19    25    29   33  43
zoites; Sc, schizonts. (B) Time course Pcalp-GFP                    ER      LR      ET         LT  LT/Sc   Sc

(clone C3) cycle. Parasites sampled 30 min analyzed flow cytometry DNA content.               100         B ER      LR    ET MT MT/LT   Sc
                                                                                                                       8
                                                                                                                                          D
                                                                            total parasites




                                                               90
Populations selected analysis shown Fig.        80                                                      7
                                                                                                                                          arbitrary units




S3. percentage total parasites pre-S phase, S        70                                                      6
                                                               60                                                      5
phase, mature schizogony represented                50                                                      4
black, red, green lines, respectively. Zero time           40                                                      3
corresponds peak mature schizonts. Dots        30
                                                                                                                                                                                                           MICROBIOLOGY




                                                                                                                       2
                                                               20
indicate harvest times protein analysis (MT, midtro-       10                                                       1
phozoites) arrow marks approximate start            0
                                                                 -5   0   5  10 15 20 25 30 35 40 45 50 55
                                                                                                                       0
                                                                                                                         8 12 16 20 24 28 32 36 40 44 S phase. (C) C3 parasites harvested                                     time (hpi)                                  time (hpi)
indicated time points, Pcalp immunoprecipitated rabbit anti-Pcalp antiserum protein blotted mouse anti-GFP antibody. BiP content measured. lane corresponds equivalent cell numbers different stages. (D) Pcalp levels quantified blots plotted time absolute values (red) ratio calpain BiP (black). point ratio omitted minimal BiP expression early rings.


Russo et al.                                                                                                                 PNAS å…© February 3, 2009 å…© vol. 106 å…©  5 å…© 1555
                                                                                   Bi




                                                                                                                  m
                                                                                                        f.
                                                                                                                           ii                                                                           v




                                                                                                      ns
                                                                                                                                                  iii                             iv




                                                                                                                 



                                                                                                                                                                                       7
                      5â€™region            HcRed-hDHFR      3â€™ region




                                                                                              7




                                                                                                                                                                         7
                                                                                                                                            kb                                                                         kb




                                                                                                                                                                                      3D
                                                                                                                      kb                                                     kb




                                                                                          3D




                                                                                                                                                                     3D
                                                                                                  tr 



                                                                                                         pl
                                                                                                                      11                     8                                8                                         8
                                     TK       X                                                                                              7                                7                                         7
                                                                                                                       9                     6                                                                          6
                                                                                                                       8                                                      6
                                                                                                                       7                    5                                                                           5
                    nat 5â€™ N-term          GFP Ahsp86-3â€™   ,hDHFR                                                                                                             5
ii              S                                  N                   S                                               6                    4                                 4                                         4
            1                                                                                                          5
                      *                                                             Ci     NS          NS(II)                S        3D7                 ii           NS            S       Plasmids 3D7
                    BstUI             Pcalp 3'                                                                                                        kb                                                               kb
iii                                                                                   2                                                              1.6         1                                                    1.6
                                                                                                                                                     1.0                                                              1.0
                                 2        1                   S                                                                                      0.8                                                              0.8
      N P                                                                       P
iv
                                                  *                                                                                                  0.5
                                                                                                                                                     0.3                                                              0.5
                                                                                                                                                                                                                      0.3
       nat 5â€™                                 Pcalp                                                                                                  0.1
                                                                                          -       +          -        +    -       +    -     +     BstUI            -        +   -        +    -   +       -      + BstUI
        D          Q G F V/V D C/C S F L S S L T                       b.    Q G F V D C S F L S S L T                                                iii      clone 1 clone 2 clone 3 clone 4                    kb
                    CAAGGTTTTGTTGCGGATTGTTCTTTTCTGTCTTCATTAAC                   CAAGGTTTTGTTGCGGATTGTTCTTTTCTGTCTTCATTAAC                                        2                                                     1.6
                               C        C                  S                                                                           NS
                                                                                                                                                                                                                     1.0
                                                                                                                                                                                                                     0.8
                                                                                                                                                                                                                     0.65
                                                                                                                                                                                                                     0.5
                                                                                                                                                                         -    +    -       +   -    +       -     + BstUI

Fig. 3. Attempted genetic strategies disrupt calpain functionality.   Diagrams vectors.   double cross gene knockout, positive selection cassette
containing HcRed-hDHFR fusion flanked Pcalp ORF 5â¬˜ 3â¬˜ ends inserted thymidine kinase (TK) negative selection vector. (ii) single cross gene disruption, sequence homologous Pcalp ORF 5â¬˜ end cloned upstream hDHFR cassette. different lengths (1.3 1.6 kb) used. Control
constructs identical contain 733 bp upstream sequence (nat 5â¬˜, brackets). (iii) allelic replacement, sequence homologous 3.8 kb Pcalp ORF 3â¬˜
end used homologous recombination. plasmids created. mutation creating new restriction site (BstUI). codons downstream active site cysteine codon (*), synonymous change, nonsynonymous change. Predicted products integration ii iii shown Fig. S4. (iv) reference Pcalp gene shown. Primers used PCR/restriction allelic replacement strategy indicated (semiarrows). Restriction
sites: X, XmaI; N, NsiI; S, SphI; P, PacI. (B) Southern blot analysis.   Double cross  Transfected parasite DNA (X/P digested) shows uninterrupted endogenous
gene (open arrow) episomal plasmid (gray arrow), evidence integration event (filled arrows). panel different exposure time. (iiâ€“v) Single
cross  DNA restricted N/S. 4 transfections control vector predicted integrations (ii iii; panels 2 blots). 4
transfections vectors gene disruption (iv v) evidence integration events (panels blot). Arrows  1.6-kb 5â¬˜ ORF ii iv; 1.3-kb 5â¬˜ ORF iii v; nat 5â¬˜ ii iii. 3D7, genomic DNA parental isolate. (C) PCR restriction screening. DNA prepared parasite culture
transfected synonymous (S) nonsynonymous (NS) vector selected integrants.   PCR performed using primer 2 amplify transcribed locus plasmids. Product incubated (â«¹) (â«º) BstUI   arrows indicate expected fragments. S vector transfectants showed evidence upstream cross (introduction restriction site), NS vector transfectant pools did. (ii) PCR performed using primer 1 amplify copies
(including plasmid) transfectants isolated plasmids (1:1 mix S NS). isolated transfected episomal plasmids restrictable. 3D7, B.
(iii) Examples isolated S clones. PCR performed primer 2; 1 4 clones shown crossed upstream. (D) Sequencing PCR products amplified S   NS (ii) integrant pools. Results control sequence analysis plasmids wild-type genomic amplicons Fig. S4.



Pcalp (Fig. 3Aii). controls used second pair constructs,                                          active site, S mutation pool identical previous ones including additional 733 bp                                            alteration codon (Fig. 3D). control, amplified upstream Pcalp ORF. controls, integration,                                                 digested active site region parental 3D7 genome, recapitulate functional 5â¬˜ UTR ahead Pcalp ORF,                                                2 plasmids isolated DNA episomes transfections disruption constructs designed generate                                                 (Fig. 3Cii). confirmed absence restrictability promoterless ORF addition truncated copy. transfec-                                            parental genome, introduction BstUI sensitivity tions repeated twice resulted transformants                                            uniquely plasmids, similarity DNA content subjected selection integrants. promoter-                                           selected transfectants.
containing constructs showed clear integration (Fig. 3Bii iii),                                          completed study isolating clones integration detectable promoterless constructs (Fig.                                             transfections better quantify proportion upstream inte-
3Biv v). results strongly suggest Pcalp essential                                      grants. isolated nearly 100 clones screened PCR product
parasite growth. data imply 733 bp upstream                                             restrictability, described (examples Fig. 3Ciii). 62 ORF adequate drive calpain expression maintain                                              NS mutation plasmid-transfected clones, detected viability.                                                                                                   upstream integration, â¬‡21  isolated S
                                                                                                             mutation transfection carried newly introduced restriction site    assess Pcalp essentiality determine proteolytic
                                                                                                             consequently mutated cysteine codon. data indicate activity enzyme required, generated 2 identical
                                                                                                             essentiality Pcalp depends proteolytic activity. Results
allelic replacement plasmids carrying 3â¬˜ thirds                                                                                                              attempts summarized Table 1.
Pcalp ORF (Fig. 3Aiii). mutations  
common plasmids, silent mutation creates new                                            Conditional Knockdown Pcalp. disruption calpain
restriction site. second mutation, 2 codons downstream                                            gene unachievable, study function protein vivo
catalytic cysteine triplet, synonymous (S) nonsynony-                                          attempted generate conditional knockdown, taking advan-
mous (NS) (Cysâ¬ŽAla). transfected 3D7 parasites selected                                               tage FKBP destabilization domain (12). 10-kDa integrants. Cross occur upstream downstream                                           FKBP domain, fused protein  targets catalytic cysteine codon. Assuming cross random                                            degradation.  presence small-molecule FKBP 3,815 bp homologous sequence, probability integration                                          ligand, Shld1, degradation mitigated. shown
upstream new restriction site 22 , downstream                                               work Plasmodium episomally expressed constructs (13). active site codon 78 , 0.16 .                                                 create conditional protein knockdown, tagged Pcalp C
specifically PCR-amplified transcribed calpain locus,                                           terminus GFP-FKBP homologous recombination 3â¬˜
BstUI-restrictable product derived S mutation integrant                                             end endogenous locus (Fig. 4A). drug cycling pool (Fig. 3Ci), indicating upstream cross occurs                                             culture constantly exposed 0.5 â?®M Shld1, obtained successful active site cysteine changed. directly                                               integration (Fig. 4B). Clones isolated representative
sequenced amplicons did detect NS mutation                                                 A7, chosen study.

1556 å…© www.pnas.orgå…¾cgiå…¾doiå…¾10.1073å…¾pnas.0806926106                                                                                                                                                             Russo et al.
                         Table 1. Calpain gene disruption attempts
                        Method                                      Purpose                          Outcome                       Attempts
                        Double cross                    Gene knockout                      0 integrations                         6
                        Single cross                    Gene recapitulation                4 integrations                         4
                                                             Gene disruption                    0 integrations                         4
                        Allelic replacement                  Synonymous mutation                7 mutations/33 clones                  1
                                                             Nonsynonymous mutation             0 mutations/62 clones                  2




   analyzed Pcalp-GFP-FKBP obtained                              fixed cells. calculated ratio percent dead
synchronized midtrophozoites grown presence absence                       parasites detected versus Shld1 (Fig. 5F). A7, Shld1. Despite low expression level, able                          dead cells absence Shld1 consistently â¬‡1.5
visualize drop calpain removal Shld1 (Fig. 4C).                       times culture maintained Shld1, experiment repeated 3 times reproducible.                              C3 control culture ratio steady â¬‡1.0. immunoprecipitation judged successful Shld1-minus lane                      difference confirmed 3 techniques correlates IgG precipitated comparable                       decreased parasitemia detected. Shld1-plus lane. low molecular weight GFP-                              analyzed microscopy appearance dead
positive bands indicated degradation sample                     parasites. Topro3-positive parasites, detected cultures workup  shown). control used C3, Pcalp-GFP                       Shld1, mature schizonts stochastically did
integrant lacks degradation domain. Calpain content                    egress properly (data shown). Surprisingly, A7 calpain
control cells affected. results strategy                  destabilized removal Shld1, detected appearance used create conditional knockdowns P. falciparum.                         type dead cell (Fig. 5G). cells trophozoites
                                                                                       appeared morphologically normal extraerythrocytic
Evidence Important Regulatory Function Pcalp G1. Growth                   inside RBC ghosts, indicating failure homeostasis asynchronous Pcalp-GFP-FKBP-expressing clones depen-                            development.
dent Shld1. removed Shld1 cultures                             surviving parasites A7 culture Shld1 observed growth inhibition 40â€“60  4 days (Fig. 5                       look morphologically abnormal slightly delayed B). control culture (Pcalp-GFP, C3) showed slight
                                                                                       transition ring trophozoite (Fig. 5H).  did
long-term toxicity drug. increasing concentrations                                                                                        careful monitoring progression asexual cycle. Using
Shld1, growth improved, reaching maximum â¬‡0.4 â?®M (Fig.
                                                                                       automated collector, harvested fixed synchronized
5C), remained constant 1 â?®M (data shown).
                                                                                       culture A7 30 min multiple cycles. samples    phenotypic analysis extended synchronized cultures                                                                                        analyzed DNA content (Fig. S5) counted percent A7 C3 clones. Shld1-maintained early schizonts split 2 portions  Shld1) closely monitored                       parasites G1 (1N), S phase (2â€“15N), late schizonts (â¬Ž15N). cell cycle flow cytometry (Fig. 5 D E). differences                   Fig. 5I shows 2 representative cycles culture presence
invasion efficiency observed.  A7 culture                          (Upper) absence (Lower) Shld1. substantial Shld1, growth defect evident trophozoite stage                    difference cycle length detected, start S phase (â¬‡20  decrease parasitemia). loss parasitemia                            absence Shld1 consistently delayed 3â€“3.5 h. correlates
maintained rest cycle detected                     peak enzyme expression (Fig. 2). data indicate cycle. defect detected control                        Pcalp knockdown leads cell death delay transitioning culture.                                                                               G1 phase trophozoite development.
   better understand drop parasitemia ring/
trophozoite transition, tested viability A7 C3                       Discussion
cultures cycle. different measurements                  characterized distinct type calpain using combinations dyes stain metabolically active                     Apicomplexa alveolates. unique N-terminal
cells (CM green), live dead cells (Syto-59 Acridine Orange                     domain, constitutes half entire protein. marked
[AcOr]), dead cells (Topro3). signals pair                      divergence mammalian calpains presence number
dyes (Sytoâ«¹CM, Toproâ«¹CM, Toproâ«¹AcOr) detected                                  clinically relevant apicomplexans make enzyme attractive
FITC APC channels compared staining obtained                          target studied.


                                                                              B     3D7 Sel1 Sel2 Sel3      clones              C IP: R-   -GFP WB: M- -GFP
                                                                                                                             kb             A7           C3
      N                                          S              N   500bp                                                               -        +   -        + Shield-1
                                                                                                                            6.0
                              Pcalp                                                                                         5.0
                                      S                               N                                                     4.0
                                                                                                                                                                   kDa
                          hDHFR                         GFP-FKBP                                                            3.0
                                          Integration                                                                                                             250
  N                                            S                            N                                                      IP inputs:
                                                                                                                                                                   75
                    N                                                                                                       2.0                                   -BiP
                                                     probe     GFP-FKBP
                                                                                                                                                                  -PM2
           C-term                                                                                                           1.0
                                                                                                                                                                   25
                                                                                                                                                                           MICROBIOLOGY




Fig. 4. Knockdown Pcalp.   Creation calpain-GFP-FKBP chimera homologous recombination. diagram shows strategy create C-terminally
tagged calpain integration endogenous locus. plasmid contains sequence Pcalp ORF 3â¬˜ end frame GFP-FKBP. Relative positions NsiI (N) SphI (S) restriction sites, probe indicated. (B) Southern blot N/S restricted DNA 3 drug cycles (Sel1â€“3) 3 clones. Arrows:
endogenous gene (black), plasmid (gray), modified calpain locus (open). (C) Western blot immunoprecipitated Pcalp-GFP (C3) Pcalp-GFP-FKBP (A7)
parasites grown presence absence Shld1. Samples processed Fig. 2B. lane corresponds equivalent numbers mid/late trophozoites.


Russo et al.                                                                                                PNAS å…© February 3, 2009 å…© vol. 106 å…©  5 å…© 1557
           13.5                                                      D 1211
  A12 A7                                                                                              A7                 Ring

                                                                                                10                                                                   G         merges    Topro3 Hoechst        Phase         H   - Shld1      + Shld1
          10.5                                                                                                                          Ring
                                                                                                 9                                                                        
  parasitemia ( )




                                                                        parasitemia ( )
             9                                                                                   8
                         7.5                                                                     7
                                                                                                 6
                           6                                                                     5
                                                                                                 4 Ring
                                                                                                                                                                          b.
                         4.5
                           3                                                                     3
                                                                                                 2                              Troph
                         1.5                                                                                  Troph
                                                                                                 1
                                                                                                   E Schiz
                          0                                                                      0


  B 109 C3                                                          E 1211                            C3                 Ring           Ring      I100                                                                                          +Shld1
                                                                                                10                                                                   80
                          8
                                                                                                 9
                                                                        parasitemia ( )
  parasitemia ( )




                          7                                                                      8
                          6                                                                      7                                                                   60                            pre S-phase = 25.5 0.5h
                          5                                                                      6
                          4                                                                      5                                                                   40
                                                                                                     Ring                                                                                         Cycle time = 42.5 0.5h




                                                                                                                                                total parasites
                                                                                                 4
                          3
                                                                                                 3
                          2                                                                      2                              Troph                         20
                          1                                                                      1            Troph
                                                                                                    E Schiz                                                    0
                          0                                                                      0
                           0.5 1    1.5      2 2.5 3      3.5   4                                 0      20      40     60      80       100
                                          time (days)                                                           time (hours)                                 100                                                                                -Shld1
                                                                                                                                                              80
 C100
   90
                                                                     F1.82
                                                                    dead par ( ) -/+ Shld1




                         80                                                                     1.6
                                                                                                                                                                     60                            pre S-phase = 28.5 1h
    total parasites




                         70                                                                     1.4
                         60                                                                     1.2                                                                  40                           Cycle time = 42 0.5h
                         50                                                                       1
                         40                                                                     0.8                                                                  20
                         30                                                                     0.6
                         20                                                                     0.4
                                                                                                0.2
                                                                                                                                                                      0
                         10                                                                                                                                           -15 -10       -5    0   5      10 15 20 25 30 35 40                  45 50 55 60
                          0                                                                       0
                           0       0.1       0.2    0.3     0.4                                       Syto+CM     Topro+CM      Topro+AcOr                                                                 time (hpi)
                                         Shld1 ( M)

Fig. 5. Analysis Pcalp knockdown phenotypes.  B) Asynchronous cultures representative clone A7   C3 (B) grown (F) (E)
0.4 â?®M Shld1 monitored time flow cytometry. X axis B. (C) Growth Pcalp-GFP-FKBP (mean 3 clones, F) C3 (äŠ?) 3 days different Shld1 concentrations. (D E) Fine analysis Shld1 growth phenotype synchronized cultures A7 (D) C3 (E). Schizonts culture
grown 0.2 â?®M Shld1 isolated allowed reinvade fresh RBCs presence (F) absence (E) Shld1. breaks indicate equal subculture
event culture. X axis D E. (F) Viability measurements using different dyes measure dead parasites A7 (light) C3 (dark) cultures. ratio â«º/â«¹ 0.2 â?®M Shld1 plotted. Flow profiles Fig. S5. (G) Appearance A7 dead parasites (Topro3-positive) fluorescence microscopy. absence Shld1 unique dead species detected: trophozoites extraerythrocytic   RBC ghosts (b). (H) Giemsa-stained smears
showed delay morphological transition ring trophozoite synchronized A7 cultures absence Shld1.   Representative cycles A7 (Upper) (Lower) Shld1. Cycle points acquired 30 min â¬‡6 days, samples fixed, DNA content analyzed flow cytometry
(Fig. S3). Green, mature schizonts; red, S phase; black, pre-S phase (G1). cycle time shown distance 2 peaks schizonts; length pre-S
phase time separating initial slope half maxima pre-S-phase S-phase peaks. Red vertical lines indicate S-phase maxima â«¹Shld1 visual
comparison â«ºShld1 culture. consistent delay start S phase detected calpain destabilized.



    Multiple efforts generate parasite clone lacking calpain                                                                                         calpain stability regulated small molecule Shld1.
expression failed, strongly suggesting absence gene                                                                                      Destabilization Pcalp yielded growth defect 40â€“60  2 incompatible optimal viability blood stages. used                                                                                       cycles. measured delay entry S phase. Morphologically,
3 different techniques. double cross gene knockout                                                                                               transition ring trophozoite delayed. Concom-
approach failed generate recombinants. Disruption single                                                                                            itantly detected increased number nonviable parasites.
cross 5â¬˜ end endogenous locus, including control                                                                                     Peaks Pcalp transcription translation normal parasites homologous recombination, new approach.                                                                                            seen pre-S-phase stages (ring mid trophozoite), native promoter recapitulated did recombination result                                                                                         sudden drop levels detected. correlates nicely
viable parasites. possible technical problems led                                                                                    observed knockdown phenotype.
failure isolate gene-disrupted recombinants 2 proce-                                                                                            absence Shld1, fusion protein degraded, resulting
dures.  designed approach, allelic replace-                                                                                       knockdown effect. remarkably scarce transcript barely
ment, overcome limitation. readily able isolate                                                                                        detectable protein levels provided challenges detection parasites cross-overs upstream active cysteine codon,                                                                                      study calpain. normal level calpain low predicted frequency, vector contained synonymous                                                                                           quantify precisely extent protein diminution. 
active site mutation. contrast, recombinants downstream                                                                                        FKBP fusions shown order magnitude nonsynonymous mutation vector used. Unlike                                                                                               range response Shld1 (ref. 13 R., unpublished results). 2 strategies, allelic replacement method generates recom-                                                                                       Assuming small number calpain molecules normal
binants missense mutation vector. site                                                                                         Gaussian distribution cells, attribute death phenotype
recombination informs gene essentiality. addition,                                                                                      cells  20  parasites) number importance active site residue informs Pcalp                                                                                           calpain molecules insufficient overcome efficiency activity necessary asexual cycle development.                                                                                                      degradation process.  cells die loss     studies insight essentiality help                                                                                    calpain function. rest cells produce just understand role enzyme cell. pursue                                                                                          calpain survive, defect pre-S-phase
developed method, based FKBP degradation domain (12,                                                                                             development. total cell cycle time normal surviving
13), generate regulated knockdown Pcalp. fusing                                                                                              parasites, suggesting able catch  cycle
GFP-FKBP tag endogenous locus generated clonal lines                                                                                            clock able proceed normal time, 
1558 å…© www.pnas.orgå…¾cgiå…¾doiå…¾10.1073å…¾pnas.0806926106                                                                                                                                                                                             Russo et al.
 Pcalp affects previous  Involvement calpain-like activity                              determined according time morphological analysis Giemsa staining. G1 3 S transitions suggested systems                                  RNA treated DNase (Gibco) checked PCR purity. Pcalp cDNA
basis indirect evidence (14, 15). S-phase delay                               amplified step RT-PCR SuperScript (Invitrogen). RT-PCR
                                                                                                  products 2 independent reactions time point analyzed
observed P. berghei parasites lacking 1 2 eEF1a genes,                                                                                                   ethidium bromide/agarose gels. Band intensity linear range. Primers case, total cell cycle prolonged (16). Given role                             Table S3.
cell cycle progression, interesting enzyme nucleolus  R., O., D.E.G., unpublished data),                                Southern Blots. Southern blots, 1 â?®g DNA digested analyzed addition rRNA synthesis ribosome assembly, key                                      previously described (25). double cross integrations screened functions cell cycle regulation (17). conclusion, developing                             PacI/XmaI digestion probed using Pcalp ORF 5â¬˜ end. single cross method regulated knockdown Pcalp, begin define                                 integrations screened NsiI/SphI digestion probing Pcalp ORF 5â¬˜ cellular role develop interesting target                                 3â¬˜ end.
antiparasitic chemotherapy.
                                                                                                  Western Blots. Protein analysis detect Pcalp immunoprecipitation Materials Methods                                                                             conducted described SI Materials Methods.
Reagents. Polyclonal antiserum   19) raised rabbits Pcalp
peptide 41â€“54. used rabbit anti-GFP ab6556 (Abcam), mouse anti-GFP JL8                    Microscopy Techniques. Live parasites observed presence Hoechst
(BD), rabbit anti-BiP (MR4), rabbit anti-plasmepsin II (18) antibodies.             33342 Topro3. Images collected Axioskop epifluorescence
reagents purchased Sigma NEB unless indicated.                                microscope (Zeiss) described (25).

Cell Cultures Transfection. P. falciparum (3D7) cultured previously                    Flow Cytometry. cell cycle analysis, highly synchronous 2  hematocrit cul-
described (19). Parasite synchronization obtained using 5  D-sorbitol                      tures, 1  parasitemia, cultivated gently rocked Roboflasks (Corning)
treatment (20), Percoll (21), magnetic separation (22). transfections, 160                ensure cell suspension. automated  controlled 3 timers â?®l 50  RBCs transfected electroporation (23) â¬‡100 â?®g purified                   composed 3 synchronized peristaltic pumps fraction collector, set 
vector DNA infected 3D7 schizonts. 72â€“90 h, 10 nM WR99210                     30 min, â¬‡150 â?®l sample culture extracted added medium. select integration, parasites cycled twice                   flask septum, sample fixed collected 4 Â°C 96 drug (24). Double cross recombination selected described                    plate. subculture, fresh, prewarmed RBCs (2  hematocrit) added
ref. 11.                                                                                          septum removing flask incubator. fixative
                                                                                                  solution (1.5 vol sample) 3.2  formaldehyde 0.01  glutaraldehyde
Sequence Phylogenetic Analysis. SI Materials Methods.                                 PBS. 5min permeabilization 0.1  Triton X-100 15 min                                                                                                   incubation â¬‡75 â?®g/ml RNase  cell DNA stained 0.5â€“1 â?®M Topro3.
Construction Vectors. Genomic DNAs extracted P. falciparum                        analysis conducted BD FACSCanto flow cytometer, monitoring
using Blood Mini Kit (Qiagen). Primers restriction sites listed Table S3.            fluorescence profiles infected RBC (Fig. S3). cloning steps confirmed sequencing. gene knockout strategy,                      viability analysis, used following dyes pairs: 1.25 â?®g/ml Cell plasmid pHHTTK (11) modified inserting HcRed coding region                         tracker-green (CM-green), 2.5 â?®M Syto59, 0.5 â?®M Topro3, 0.4 â?®g/ml AcOr
upstream hDHFR. backbone, cloned 5â¬˜ 3â¬˜ ends Pcalp                  (Molecular Probes). Metabolically active cells incorporated CM-green ORF. constructs gene disruption single cross                       15-min incubation 37 Â°C. analyzed flow cytometry calpain N-terminal coding regions (1.3 1.6 kb) 733 bp 5â¬˜                   presence DNA dyes, cell-permeant Syto59, cell-impermeant Topro3. UTR PCR amplified genomic DNA cloned pPM2GT (25).                            viability measurement based use 2 DNA dyes time,
vectors allelic replacement generated cloning 3.8 kb Pcalp 3â¬˜ ORF                  AcOr Topro3. Control dead cells produced fixing culture. pPM2GT (25). Mutagenesis allelic replacement vectors                    analysis conducted recording green far-red fluorescence profiles QuikChange kit (Stratagene). vectors 3â¬˜ tagging constructed                   infected RBCs (Fig. S5).
cloning 1.1 kb 3â¬˜ Pcalp ORF pPM2GT (25) generate Pcalp-GFP replacing GFP GFP-FKBP generate Pcalp-GFP-FKBP. FKBP domain                       ACKNOWLEDGMENTS. thank Sanger Broad Institutes DNA
amplified pBMN YFP-L106P (12).                                                               sequences; Jacobus Pharmaceutical WR99210; T. Wandless (Stanford Uni-
 